Malomin Tablet

About Malomin 25 mg Tablet

Malomin 25 mg is a tablet product of Sonear Laboratories Ltd. that contains Pyrimethamine. It is also used for acute malaria, but never alone; it must be combined with a faster-acting anti-malarial such as chloroquine.

There are 2 brands of Pyrimethamine listed in Bangladesh. The lowest listed price is Pyrison 25 mg Tablet at ৳ 1 per unit.

What is Malomin 25 mg Tablet?

The tablet Malomin contains Pyrimethamine and is made by Sonear Laboratories Ltd. Pyrimethamine works by interfering with how the parasites make folate, a substance they need to survive. It is prescribed for two main conditions: toxoplasmosis, where it is used together with a sulfonamide medicine, and acute malaria. The doctor decides the dose and course.

Uses of Malomin

It is also used for acute malaria, but never alone; it must be combined with a faster-acting anti-malarial such as chloroquine. The doctor will determine whether this medicine is suitable for the specific infection. Malomin is used to treat toxoplasmosis when given together with a sulfonamide, as the two medicines work better in combination. Your doctor will decide if it is suitable for you.

How to use Malomin

Malomin tablets are taken by mouth. Swallow the tablet with water. Take Malomin exactly as your doctor tells you. Do not change the dose or stop treatment without medical advice. Follow the doctor's instructions carefully.

Side effects of Malomin

At doses used for toxoplasmosis, loss of appetite and vomiting are possible; taking the medicine with meals may help, and vomiting usually stops if the dose is reduced. Side effects can include allergic reactions, which may occasionally be severe, such as skin rashes or swelling. The doctor will monitor for other effects. Tell your doctor if any side effect bothers you or does not go away. Contact your doctor if you notice anything unusual after taking it.

Safety and precautions

Malomin should not be used by anyone with a known allergy to Pyrimethamine or any ingredient, or with megaloblastic anemia due to folate deficiency. People with kidney or liver problems, folate deficiency, alcoholism, or those taking certain other medicines should tell the doctor before using it. It is pregnancy category C, meaning it may harm an unborn baby; discuss pregnancy or breastfeeding with the doctor first. Tell your doctor about all the other medicines you take.

Frequently asked questions

Why is Malomin prescribed?

It is also used for acute malaria, but never alone; it must be combined with a faster-acting anti-malarial such as chloroquine. The doctor will determine whether this medicine is suitable for the specific infection.

How is Malomin used?

Malomin tablets are taken by mouth. Swallow the tablet with water.

What should I watch for while using Malomin?

At doses used for toxoplasmosis, loss of appetite and vomiting are possible; taking the medicine with meals may help, and vomiting usually stops if the dose is reduced. Side effects can include allergic reactions, which may occasionally be severe, such as skin rashes or swelling.

Who should be careful with Malomin?

Malomin should not be used by anyone with a known allergy to Pyrimethamine or any ingredient, or with megaloblastic anemia due to folate deficiency. People with kidney or liver problems, folate deficiency, alcoholism, or those taking certain other medicines should tell the doctor before using it.

Indications

Treatment of Toxoplasmosis: Pyrimethamine is indicated for the treatment of toxoplasmosis when used conjointly with a sulfonamide, since synergism exists with this combination.

Treatment of Acute Malaria: Pyrimethamine is also indicated for the treatment ... Read moreTreatment of Toxoplasmosis: Pyrimethamine is indicated for the treatment of toxoplasmosis when used conjointly with a sulfonamide, since synergism exists with this combination.

Treatment of Acute Malaria: Pyrimethamine is also indicated for the treatment of acute malaria. It should not be used alone to treat acute malaria. Fast-acting schizonticides such as chloroquine or quinine are indicated and preferable for the treatment of acute malaria. However, conjoint use of Pyrimethamine with a sulfonamide (e.g., sulfadoxine) will initiate transmission control and suppression of susceptible strains of plasmodia.

Chemoprophylaxis of Malaria: Pyrimethamine is indicated for the chemoprophylaxis of malaria due to susceptible strains of plasmodia. However, resistance to pyrimethamine is prevalent worldwide. It is not suitable as a prophylactic agent for travelers to most areas.

Pharmacology

Pyrimethamine is a folic acid antagonist structurally similar to trimethoprim. It inhibits parasitic dihydrofolate reductase, thus inhibiting vital tetrahydrofolic acid synthesis. It is active against pre-erythrocytic forms and is also a slow-acting schizontocide.

Dosage & Administration

For Treatment of Toxoplasmosis: The dosage of Pyrimethamine for the treatment of toxoplasmosis must be carefully adjusted so as to provide maximum therapeutic effect and a minimum of side effects. At the dosage required, there is a marked variation in the tolerance to the drug. Young patients may tolerate higher doses than older individuals. Concurrent administration of folinic acid is strongly recommended in all patients.

The adult starting dose is 50 to 75 mg of the drug daily, together with 1 to 4 g daily of a sulfonamide of the sulfapyrimidine type, e.g. sulfadoxine. This dosage is ordinarily continued for 1 to 3 weeks, depending on the response of the patient and tolerance to therapy. The dosage may then be reduced to about one half that previously given for each drug and continued for an additional 4 to 5 weeks.

The pediatric dosage of Pyrimethamine is 1 mg/kg/day divided into 2 equal daily doses; after 2 to 4 days this dose may be reduced to one half and continued for approximately 1 month. The usual pediatric sulfonamide dosage is used in conjunction with Pyrimethamine.

For Treatment of Acute Malaria: Pyrimethamine is NOT recommended alone in the treatment of acute malaria. Fast-acting schizonticides, such as chloroquine or quinine, are indicated for treatment of acute malaria. However, Pyrimethamine at a dosage of 25 mg daily for 2 days with a sulfonamide will initiate transmission control and suppression of non-falciparum malaria. Pyrimethamine is only recommended for patients infected in areas where susceptible plasmodia exist. Should circumstances arise wherein Pyrimethamine must be used alone in semi- immune persons, the adult dosage for acute malaria is 50 mg for 2 days; children 4 through 10 years old may be given 25 mg daily for 2 days. In any event, clinical cure should be followed by the once-weekly regimen described below for chemoprophylaxis. Regimens which include suppression should be extended through any characteristic periods of early recrudescence and late relapse, i.e., for at least 10 weeks in each case.

For Chemoprophylaxis of Malaria:
  • Adults and pediatric patients over 10 years: 25 mg (1 tablet) once weekly
  • Children 4 through 10 years: 12.5 mg (½ tablet) once weekly
  • Infants and children under 4 years: 6.25 mg (¼ tablet) once weekly.

Interaction

Pyrimethamine may be used with sulfonamides, quinine and other antimalarials, and with other antibiotics. However, the concomitant use of other antifolic drugs or agents associated with myelosuppression including sulfonamides or trimethoprim-sulfamethoxazole combinations, proguanil, zidovudine, or cytostatic agents (e.g., methotrexate), while the patient is receiving pyrimethamine, may increase the risk of bone marrow suppression. If signs of folate deficiency develop, pyrimethamine should be discontinued. Folinic acid (leucovorin) should be administered until normal hematopoiesis is restored

Contraindications

Use of Pyrimethamine is contraindicated in patients with known hypersensitivity to pyrimethamine or to any component of the formulation. Use of the drug is also contraindicated in patients with documented megaloblastic anemia due to folate deficiency.

Side Effects

Hypersensitivity reactions, occasionally severe (such as Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, and anaphylaxis), and hyperphenylalaninemia, can occur particularly when pyrimethamine is administered concomitantly with a sulfonamide. Consult the complete prescribing information for the relevant sulfonamide for sulfonamideassociated adverse events. With doses of pyrimethamine used for the treatment of toxoplasmosis, anorexia and vomiting may occur. Vomiting may be minimized by giving the medication with meals; it usually disappears promptly upon reduction of dosage. Doses used in toxoplasmosis may produce megaloblastic anemia, leukopenia, thrombocytopenia, pancytopenia, neutropenia, atrophic glossitis, hematuria, and disorders of cardiac rhythm.

Pregnancy & Lactation

Pregnancy Category C. Pyrimethamine has been shown to be teratogenic in rats when given in oral doses 7 times the human dose for chemoprophylaxis of malaria or 2.5 times the human dose for treatment of toxoplasmosis. At these doses in rats, there was a significant increase in abnormalities such as cleft palate, brachygnathia, oligodactyly, and microphthalmia. Pyrimethamine has also been shown to produce terata such as meningocele in hamsters and cleft palate in miniature pigs when given in oral doses 170 and 5 times the human dose, respectively, for chemoprophylaxis of malaria or for treatment of toxoplasmosis.

There are no adequate and well-controlled studies in pregnant women. Pyrimethamine should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

Concurrent administration of folinic acid is strongly recommended when used for the treatment of toxoplasmosis during pregnancy.

Nursing Mothers: Pyrimethamine is excreted in human milk. Because of the potential for serious adverse reactions in nursing infants from pyrimethamine and from concurrent use of a sulfonamide with Pyrimethamine for treatment of some patients with toxoplasmosis, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother

Precautions & Warnings

The recommended dosage for chemoprophylaxis of malaria should not be exceeded. Pyrimethamine should be used with caution in patients with impaired renal or hepatic function or in patients with possible folate deficiency, such as individuals with malabsorption syndrome, alcoholism, or pregnancy, and those receiving therapy, such as phenytoin, affecting folate levels

Alternative brands of Pyrimethamine

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.